scispace - formally typeset
A

Ahmedin Jemal

Researcher at American Cancer Society

Publications -  568
Citations -  492750

Ahmedin Jemal is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 132, co-authored 500 publications receiving 380474 citations. Previous affiliations of Ahmedin Jemal include Centers for Disease Control and Prevention & Emory University.

Papers
More filters
Journal ArticleDOI

2016 US lymphoid malignancy statistics by World Health Organization subtypes.

TL;DR: Estimates of the total numbers of US lymphoid neoplasm cases by subtype as well as a detailed evaluation of incidence and survival statistics are presented, which can offer clues regarding their etiology.
Journal ArticleDOI

Annual Report to the Nation on the Status of Cancer, 1975–2007, Featuring Tumors of the Brain and Other Nervous System

TL;DR: The decrease in cancer incidence and mortality reflects progress in cancer prevention, early detection, and treatment, however, major challenges remain, including increasing incidence rates and continued low survival for some cancers.
Journal ArticleDOI

Trends in Breast Cancer by Race and Ethnicity: Update 2006

TL;DR: Estimates of new breast cancer cases and deaths in 2006 are provided and trends in incidence, mortality, and survival for female breast cancer in the United States are described and trends are described.
Journal ArticleDOI

International variations and trends in renal cell carcinoma incidence and mortality

TL;DR: Although RCC incidence is still increasing in most countries, stabilisation of mortality trends has been achieved in many highly developed countries and there are marked absolute differences and opposing RCC mortality trends in countries categorised as areas of higher versus lower human development, and these gaps appear to be widening.
Journal ArticleDOI

Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities

TL;DR: Although blacks continue to have higher cancer death rates than whites, the disparity has narrowed and the racial gap in death rates has widened for all cancers combined in men and women and for lung and prostate cancers in men.